Exos Asset Management’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

Exos Asset Management’s Portfolio ORIAW Stock Details ORIAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-11,000	Closed	-$10K	–	429
2021 Q3	$10K	Buy	+11,000	New	+$14.3K	0.01%	417

Other funds holding ORIAW

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Segantii Capital Management Hong Kong $1.02B AUM 16.73% 1-Year Est. Return

683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return

Fir Tree Capital Management New York $5.03M AUM 3.16% 1-Year Est. Return

Cantor Fitzgerald New York $2.76B AUM 29.01% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return

Anson Funds Management Dallas, Texas $1.57B AUM 370.24% 1-Year Est. Return